{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T02:24:49Z","timestamp":1769826289008,"version":"3.49.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,2,23]],"date-time":"2008-02-23T00:00:00Z","timestamp":1203724800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Immunopathol"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1007\/s00281-008-0113-8","type":"journal-article","created":{"date-parts":[[2008,2,22]],"date-time":"2008-02-22T08:28:11Z","timestamp":1203668891000},"page":"111-119","source":"Crossref","is-referenced-by-count":38,"title":["Angiogenesis in eye disease: immunity gained or immunity lost?"],"prefix":"10.1007","volume":"30","author":[{"given":"Thomas A.","family":"Ferguson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajendra S.","family":"Apte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,2,23]]},"reference":[{"issue":"11","key":"113_CR1","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1074-5521(96)90176-3","volume":"3","author":"S Stromblad","year":"1996","unstructured":"Stromblad S, Cheresh DA (1996) Integrins, angiogenesis and vascular cell survival. Chem Biol 3(11):881\u2013885","journal-title":"Chem Biol"},{"issue":"6","key":"113_CR2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1096\/fasebj.11.6.9194526","volume":"11","author":"JR Jackson","year":"1997","unstructured":"Jackson JR et al (1997) The codependence of angiogenesis and chronic inflammation. Faseb J 11(6):457\u2013465","journal-title":"Faseb J"},{"issue":"7","key":"113_CR3","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1182\/blood-2006-04-013755","volume":"108","author":"BJ Capoccia","year":"2006","unstructured":"Capoccia BJ et al (2006) G-CSF and AMD3100 mobilize monocytes into the blood that stimulate angiogenesis in vivo through a paracrine mechanism. Blood 108(7):2438\u20132445","journal-title":"Blood"},{"issue":"9","key":"113_CR4","first-page":"1929","volume":"37","author":"A Kvanta","year":"1996","unstructured":"Kvanta A et al (1996) Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest Ophthalmol Vis Sci 37(9):1929\u20131934","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"113_CR5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF00941723","volume":"235","author":"T Ishibashi","year":"1997","unstructured":"Ishibashi T et al (1997) Expression of vascular endothelial growth factor in experimental choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 235(3):159\u2013167","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"113_CR6","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000055489","volume":"30","author":"X Liu","year":"1998","unstructured":"Liu X et al (1998) Regulatory effects of soluble growth factors on choriocapillaris endothelial growth and survival. Ophthalmic Res 30(5):302\u2013313","journal-title":"Ophthalmic Res"},{"issue":"3","key":"113_CR7","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1073\/pnas.92.3.905","volume":"92","author":"EA Pierce","year":"1995","unstructured":"Pierce EA et al (1995) Vascular endothelial growth factor\/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci U S A 92(3):905\u2013909","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"113_CR8","first-page":"899","volume":"31","author":"H Miller","year":"1990","unstructured":"Miller H et al (1990) Pathogenesis of laser-induced choroidal subretinal neovascularization. Invest Ophthalmol Vis Sci 31(5):899\u2013908","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"113_CR9","first-page":"3974","volume":"35","author":"PA D\u2019Amore","year":"1994","unstructured":"D\u2019Amore PA (1994) Mechanisms of retinal and choroidal neovascularization. Invest Ophthalmol Vis Sci 35(12):3974\u20133979","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"113_CR10","first-page":"563","volume":"75","author":"J Luna","year":"1996","unstructured":"Luna J et al (1996) Antagonists of integrin alpha v beta 3 inhibit retinal neovascularization in a murine model. Lab Invest 75(4):563\u2013573","journal-title":"Lab Invest"},{"issue":"14","key":"113_CR11","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","volume":"355","author":"PJ Rosenfeld","year":"2006","unstructured":"Rosenfeld PJ et al (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355(14):1419\u20131431","journal-title":"N Engl J Med"},{"issue":"5425","key":"113_CR12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1126\/science.285.5425.245","volume":"285","author":"DW Dawson","year":"1999","unstructured":"Dawson DW et al (1999) Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 285(5425):245\u2013248","journal-title":"Science"},{"issue":"5","key":"113_CR13","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1073\/pnas.031252398","volume":"98","author":"V Stellmach","year":"2001","unstructured":"Stellmach V et al (2001) Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor. Proc Natl Acad Sci U S A 98(5):2593\u20132597","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"113_CR14","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nm870","volume":"9","author":"JA Doll","year":"2003","unstructured":"Doll JA et al (2003) Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas. Nat Med 9(6):774\u2013780","journal-title":"Nat Med"},{"issue":"7114","key":"113_CR15","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nature05249","volume":"443","author":"BK Ambati","year":"2006","unstructured":"Ambati BK et al (2006) Corneal avascularity is due to soluble VEGF receptor-1. Nature 443(7114):993\u2013997","journal-title":"Nature"},{"issue":"3","key":"113_CR16","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/6509","volume":"5","author":"HJ Kaplan","year":"1999","unstructured":"Kaplan HJ et al (1999) Fas ligand (CD95 ligand) controls angiogenesis beneath the retina. Nat Med 5(3):292\u2013297","journal-title":"Nat Med"},{"issue":"8","key":"113_CR17","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1371\/journal.pmed.0030310","volume":"3","author":"RS Apte","year":"2006","unstructured":"Apte RS et al (2006) Macrophages inhibit neovascularization in a murine model of age-related macular degeneration. PLoS Med 3(8):e310","journal-title":"PLoS Med"},{"issue":"11","key":"113_CR18","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1172\/JCI32430","volume":"117","author":"J Kelly","year":"2007","unstructured":"Kelly J et al (2007) Senescence regulates macrophage activation and angiogenic fate at sites of tissue injury in mice. J Clin Invest 117(11):3421\u20133426","journal-title":"J Clin Invest"},{"issue":"3","key":"113_CR19","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI119173","volume":"99","author":"PM Stuart","year":"1997","unstructured":"Stuart PM et al (1997) CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J Clin Invest 99(3):396\u2013402","journal-title":"J Clin Invest"},{"issue":"1","key":"113_CR20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1167\/iovs.02-0299","volume":"44","author":"PM Stuart","year":"2003","unstructured":"Stuart PM et al (2003) FasL\u2013Fas interactions regulate neovascularization in the cornea. Invest Ophthalmol Vis Sci 44(1):93\u201398","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"113_CR21","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1167\/iovs.02-0478","volume":"44","author":"R Barreiro","year":"2003","unstructured":"Barreiro R et al (2003) The role of Fas\u2013FasL in the development and treatment of ischemic retinopathy. Invest Ophthalmol Vis Sci 44(3):1282\u20131286","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"113_CR22","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1167\/iovs.03-0050","volume":"44","author":"MH Davies","year":"2003","unstructured":"Davies MH et al (2003) Increased retinal neovascularization in Fas ligand-deficient mice. Invest Ophthalmol Vis Sci 44(7):3202\u20133210","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"113_CR23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-1-4899-0274-0_12","volume":"406","author":"S Nagata","year":"1996","unstructured":"Nagata S (1996) Fas-mediated apoptosis. Adv Exp Med Biol 406:119\u2013124","journal-title":"Adv Exp Med Biol"},{"issue":"3\u20134","key":"113_CR24","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S1359-6101(03)00028-5","volume":"14","author":"HO Lee","year":"2003","unstructured":"Lee HO, Ferguson TA (2003) Biology of FasL. Cytokine Growth Factor Rev 14(3\u20134):325\u2013335","journal-title":"Cytokine Growth Factor Rev"},{"issue":"5239","key":"113_CR25","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1126\/science.270.5239.1189","volume":"270","author":"TS Griffith","year":"1995","unstructured":"Griffith TS et al (1995) Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270(5239):1189\u20131192","journal-title":"Science"},{"key":"113_CR26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-065X.1997.tb00967.x","volume":"156","author":"TA Ferguson","year":"1997","unstructured":"Ferguson TA, Griffith TS (1997) A vision of cell death: insights into immune privilege. Immunol Rev 156:167\u2013184","journal-title":"Immunol Rev"},{"issue":"1","key":"113_CR27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0167-5699(98)01382-6","volume":"20","author":"J O\u2019Connell","year":"1999","unstructured":"O\u2019Connell J et al (1999) The Fas counterattack: cancer as a site of immune privilege. Immunol Today 20(1):46\u201352","journal-title":"Immunol Today"},{"issue":"5291","key":"113_CR28","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1126\/science.274.5291.1363","volume":"274","author":"M Hahne","year":"1996","unstructured":"Hahne M et al (1996) Melanoma cell expression of Fas(Apo-1\/CD95) ligand: implications for tumor immune escape. Science 274(5291):1363\u20131366","journal-title":"Science"},{"key":"113_CR29","first-page":"161","volume":"97","author":"T Brunner","year":"1996","unstructured":"Brunner T et al (1996) Regulation of CD95 ligand expression: a key element in immune regulation? Behring Inst Mitt 97:161\u2013174","journal-title":"Behring Inst Mitt"},{"issue":"6","key":"113_CR30","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1172\/JCI8236","volume":"105","author":"HG Zhang","year":"2000","unstructured":"Zhang HG et al (2000) Antigen presenting cells expressing Fas ligand down-modulate chronic inflammatory disease in Fas ligand-deficient mice. J Clin Invest 105(6):813\u2013821","journal-title":"J Clin Invest"},{"issue":"5","key":"113_CR31","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S1074-7613(00)80668-8","volume":"9","author":"E Bonfoco","year":"1998","unstructured":"Bonfoco E et al (1998) Inducible nonlymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells. Immunity 9(5):711\u2013720","journal-title":"Immunity"},{"issue":"1","key":"113_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1027343210080","volume":"17","author":"TA Ferguson","year":"1997","unstructured":"Ferguson TA, Griffith TS (1997) Cell death and the immune response: a lesson from the privileged. J Clin Immunol 17(1):1\u201310","journal-title":"J Clin Immunol"},{"issue":"12","key":"113_CR33","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/35103104","volume":"2","author":"DR Green","year":"2001","unstructured":"Green DR, Ferguson TA (2001) The role of Fas ligand in immune privilege. Nat Rev Mol Cell Biol 2(12):917\u2013924","journal-title":"Nat Rev Mol Cell Biol"},{"key":"113_CR34","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1146\/annurev.immunol.23.021704.115816","volume":"23","author":"PR Taylor","year":"2005","unstructured":"Taylor PR et al (2005) Macrophage receptors and immune recognition. Annu Rev Immunol 23:901\u2013944","journal-title":"Annu Rev Immunol"},{"issue":"11","key":"113_CR35","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1172\/JCI23298","volume":"115","author":"S Nakao","year":"2005","unstructured":"Nakao S et al (2005) Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth. J Clin Invest 115(11):2979\u20132991","journal-title":"J Clin Invest"},{"issue":"2","key":"113_CR36","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1006\/geno.1995.9876","volume":"30","author":"J Balciuniene","year":"1995","unstructured":"Balciuniene J et al (1995) A gene for autosomal dominant progressive cone dystrophy (CORD5) maps to chromosome 17p12-p13. Genomics 30(2):281\u2013286","journal-title":"Genomics"},{"issue":"5720","key":"113_CR37","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1109557","volume":"308","author":"RJ Klein","year":"2005","unstructured":"Klein RJ et al (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308(5720):385\u2013389","journal-title":"Science"},{"issue":"9","key":"113_CR38","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1023\/A:1025643303914","volume":"18","author":"R Leeuwen van","year":"2003","unstructured":"van Leeuwen R et al (2003) Epidemiology of age-related maculopathy: a review. Eur J Epidemiol 18(9):845\u2013854","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"113_CR39","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0002-9394(02)01624-0","volume":"134","author":"DH Anderson","year":"2002","unstructured":"Anderson DH et al (2002) A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 134(3):411\u2013431","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"113_CR40","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrn2007","volume":"7","author":"A Rattner","year":"2006","unstructured":"Rattner A, Nathans J (2006) Macular degeneration: recent advances and therapeutic opportunities. Nat Rev Neurosci 7(11):860\u2013872","journal-title":"Nat Rev Neurosci"},{"issue":"11","key":"113_CR41","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/nm950","volume":"9","author":"J Ambati","year":"2003","unstructured":"Ambati J et al (2003) An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat Med 9(11):1390\u20131397","journal-title":"Nat Med"},{"issue":"8","key":"113_CR42","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1167\/iovs.03-0038","volume":"44","author":"DG Espinosa-Heidmann","year":"2003","unstructured":"Espinosa-Heidmann DG et al (2003) Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 44(8):3586\u20133592","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"20","key":"113_CR43","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.1073\/pnas.0502819102","volume":"102","author":"D Bok","year":"2005","unstructured":"Bok D (2005) Evidence for an inflammatory process in age-related macular degeneration gains new support. Proc Natl Acad Sci U S A 102(20):7053\u20137054","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"113_CR44","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1167\/iovs.03-0097","volume":"44","author":"E Sakurai","year":"2003","unstructured":"Sakurai E et al (2003) Macrophage depletion inhibits experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 44(8):3578\u20133585","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5720","key":"113_CR45","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1126\/science.1110359","volume":"308","author":"JL Haines","year":"2005","unstructured":"Haines JL et al (2005) Complement factor H variant increases the risk of age-related macular degeneration. Science 308(5720):419\u2013421","journal-title":"Science"},{"issue":"5720","key":"113_CR46","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1126\/science.1110189","volume":"308","author":"AO Edwards","year":"2005","unstructured":"Edwards AO et al (2005) Complement factor H polymorphism and age-related macular degeneration. Science 308(5720):421\u2013424","journal-title":"Science"},{"issue":"20","key":"113_CR47","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.1073\/pnas.0501536102","volume":"102","author":"GS Hageman","year":"2005","unstructured":"Hageman GS et al (2005) A common haplotype in the complement regulatory gene factor H (HF1\/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 102(20):7227\u20137232","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"113_CR48","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.4049\/jimmunol.178.3.1783","volume":"178","author":"NS Bora","year":"2007","unstructured":"Bora NS et al (2007) CD59, a complement regulatory protein, controls choroidal neovascularization in a mouse model of wet-type age-related macular degeneration. J Immunol 178(3):1783\u20131790","journal-title":"J Immunol"},{"issue":"3","key":"113_CR49","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.4049\/jimmunol.177.3.1872","volume":"177","author":"NS Bora","year":"2006","unstructured":"Bora NS et al (2006) Complement activation via alternative pathway is critical in the development of laser-induced choroidal neovascularization: role of factor B and factor H. J Immunol 177(3):1872\u20131878","journal-title":"J Immunol"},{"issue":"1","key":"113_CR50","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1189\/jlb.0902436","volume":"74","author":"C Tsutsumi","year":"2003","unstructured":"Tsutsumi C et al (2003) The critical role of ocular-infiltrating macrophages in the development of choroidal neovascularization. J Leukoc Biol 74(1):25\u201332","journal-title":"J Leukoc Biol"},{"issue":"7057","key":"113_CR51","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature03928","volume":"437","author":"IB Lobov","year":"2005","unstructured":"Lobov IB et al (2005) WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature. Nature 437(7057):417\u2013421","journal-title":"Nature"},{"issue":"1","key":"113_CR52","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nri978","volume":"3","author":"S Gordon","year":"2003","unstructured":"Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3(1):23\u201335","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"113_CR53","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.immuni.2005.10.001","volume":"23","author":"A Mantovani","year":"2005","unstructured":"Mantovani A et al (2005) Macrophage polarization comes of age. Immunity 23(4):344\u2013346","journal-title":"Immunity"},{"issue":"5","key":"113_CR54","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/bjo.83.5.598","volume":"83","author":"PG McMenamin","year":"1999","unstructured":"McMenamin PG (1999) Dendritic cells and macrophages in the uveal tract of the normal mouse eye. Br J Ophthalmol 83(5):598\u2013604","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"113_CR55","first-page":"83","volume":"2","author":"JY Niederkorn","year":"1989","unstructured":"Niederkorn JY et al (1989) Phagocytosis of particulate antigens by corneal epithelial cells stimulates interleukin-1 secretion and migration of Langerhans cells into the central cornea. Reg Immunol 2(2):83\u201390","journal-title":"Reg Immunol"},{"issue":"1","key":"113_CR56","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1172\/JCI28549","volume":"117","author":"F Tacke","year":"2007","unstructured":"Tacke F et al (2007) Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 117(1):185\u2013194","journal-title":"J Clin Invest"},{"issue":"46","key":"113_CR57","doi-asserted-by":"crossref","first-page":"17456","DOI":"10.1073\/pnas.0606234103","volume":"103","author":"PT Johnson","year":"2006","unstructured":"Johnson PT et al (2006) Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid. Proc Natl Acad Sci U S A 103(46):17456\u201317461","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"113_CR58","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1080\/07853890600946724","volume":"38","author":"KM Gehrs","year":"2006","unstructured":"Gehrs KM et al (2006) Age-related macular degeneration\u2014emerging pathogenetic and therapeutic concepts. Ann Med 38(7):450\u2013471","journal-title":"Ann Med"},{"issue":"1","key":"113_CR59","doi-asserted-by":"crossref","first-page":"342","DOI":"10.4049\/jimmunol.175.1.342","volume":"175","author":"RD Stout","year":"2005","unstructured":"Stout RD et al (2005) Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J Immunol 175(1):342\u2013349","journal-title":"J Immunol"},{"issue":"1","key":"113_CR60","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1042\/cs1040027","volume":"104","author":"JS Duffield","year":"2003","unstructured":"Duffield JS (2003) The inflammatory macrophage: a story of Jekyll and Hyde. Clin Sci (Lond) 104(1):27\u201338","journal-title":"Clin Sci (Lond)"},{"key":"113_CR61","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1182\/blood-2005-04-1485","volume":"108","author":"G Hassanzadeh Ghassabeh","year":"2006","unstructured":"Hassanzadeh Ghassabeh G, et al. (2006) Identification of a common gene signature for type II cytokine-associated myeloid cells elicited in vivo during different pathologies. Blood 108:575\u2013583","journal-title":"Blood"},{"issue":"6","key":"113_CR62","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ejca.2006.01.003","volume":"42","author":"A Sica","year":"2006","unstructured":"Sica A et al (2006) Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 42(6):717\u2013727","journal-title":"Eur J Cancer"},{"issue":"5","key":"113_CR63","first-page":"1567","volume":"43","author":"DG Espinosa-Heidmann","year":"2002","unstructured":"Espinosa-Heidmann DG et al (2002) Age as an independent risk factor for severity of experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 43(5):1567\u20131573","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"113_CR64","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S0531-5565(02)00125-0","volume":"37","author":"J Lloberas","year":"2002","unstructured":"Lloberas J, Celada A (2002) Effect of aging on macrophage function. Exp Gerontol 37(12):1325\u20131331","journal-title":"Exp Gerontol"},{"issue":"5","key":"113_CR65","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.coi.2005.07.013","volume":"17","author":"CR Gomez","year":"2005","unstructured":"Gomez CR et al (2005) The aging innate immune system. Curr Opin Immunol 17(5):457\u2013462","journal-title":"Curr Opin Immunol"},{"issue":"5","key":"113_CR66","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0167-5699(97)81663-5","volume":"18","author":"TS Griffith","year":"1997","unstructured":"Griffith TS, Ferguson TA (1997) The role of FasL-induced apoptosis in immune privilege. Immunol Today 18(5):240\u2013244","journal-title":"Immunol Today"},{"key":"113_CR67","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1600-065X.2006.00430.x","volume":"213","author":"TA Ferguson","year":"2006","unstructured":"Ferguson TA, Griffith TS (2006) A vision of cell death: Fas ligand and immune privilege 10\u00a0years later. Immunol Rev 213:228\u2013238","journal-title":"Immunol Rev"},{"issue":"10","key":"113_CR68","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1172\/JCI31692","volume":"117","author":"C Combadiere","year":"2007","unstructured":"Combadiere C et al (2007) CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J Clin Invest 117(10):2920\u20132928","journal-title":"J Clin Invest"},{"issue":"6","key":"113_CR69","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1056\/NEJMoa072618","volume":"357","author":"JR Yates","year":"2007","unstructured":"Yates JR et al (2007) Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med 357(6):553\u2013561","journal-title":"N Engl J Med"},{"issue":"4","key":"113_CR70","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ng912","volume":"31","author":"MC Pickering","year":"2002","unstructured":"Pickering MC et al (2002) Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat Genet 31(4):424\u2013428","journal-title":"Nat Genet"},{"key":"113_CR71","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000075692","volume":"7","author":"RJ Quigg","year":"2004","unstructured":"Quigg RJ (2004) Complement and autoimmune glomerular diseases. Curr Dir Autoimmun 7:165\u2013180","journal-title":"Curr Dir Autoimmun"},{"issue":"42","key":"113_CR72","doi-asserted-by":"crossref","first-page":"16651","DOI":"10.1073\/pnas.0705079104","volume":"104","author":"PJ Coffey","year":"2007","unstructured":"Coffey PJ et al (2007) Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction. Proc Natl Acad Sci U S A 104(42):16651\u201316656","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"113_CR73","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0002-9394(14)77270-8","volume":"112","author":"PF Lopez","year":"1991","unstructured":"Lopez PF et al (1991) Pathologic features of surgically excised subretinal neovascular membranes in age-related macular degeneration. Am J Ophthalmol 112(6):647\u2013656","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"113_CR74","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3109\/10611860008997910","volume":"8","author":"E Papadimitriou","year":"2000","unstructured":"Papadimitriou E, Antimisiaris SG (2000) Interactions of PC\/Chol and PS\/Chol liposomes with human cells in vitro. J Drug Target 8(5):335\u2013351","journal-title":"J Drug Target"},{"issue":"4","key":"113_CR75","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/ijc.11108","volume":"105","author":"S Krasnici","year":"2003","unstructured":"Krasnici S et al (2003) Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels. Int J Cancer 105(4):561\u2013567","journal-title":"Int J Cancer"},{"issue":"3","key":"113_CR76","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1350-9462(00)00025-2","volume":"20","author":"PL Penfold","year":"2001","unstructured":"Penfold PL et al (2001) Immunological and aetiological aspects of macular degeneration. Prog Retin Eye Res 20(3):385\u2013414","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"113_CR77","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1365-2567.2005.02173.x","volume":"115","author":"N Patel","year":"2005","unstructured":"Patel N et al (2005) Circulating anti-retinal antibodies as immune markers in age-related macular degeneration. Immunology 115(3):422\u2013430","journal-title":"Immunology"},{"issue":"6","key":"113_CR78","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1442-9071.2006.01281.x","volume":"34","author":"S Cherepanoff","year":"2006","unstructured":"Cherepanoff S et al (2006) Retinal autoantibody profile in early age-related macular degeneration: preliminary findings from the Blue Mountains Eye Study. Clin Experiment Ophthalmol 34(6):590\u2013595","journal-title":"Clin Experiment Ophthalmol"},{"issue":"2","key":"113_CR79","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00004397-200004000-00009","volume":"40","author":"IC Kuo","year":"2000","unstructured":"Kuo IC, Cunningham ET Jr. (2000) Ocular neovascularization in patients with uveitis. Int Ophthalmol Clin 40(2):111\u2013126","journal-title":"Int Ophthalmol Clin"},{"issue":"9","key":"113_CR80","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.4049\/jimmunol.169.9.4739","volume":"169","author":"HO Lee","year":"2002","unstructured":"Lee HO et al (2002) TRAIL: a mechanism of tumor surveillance in an immune privileged site. J Immunol 169(9):4739\u20134744","journal-title":"J Immunol"}],"container-title":["Seminars in Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-008-0113-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00281-008-0113-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-008-0113-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T10:11:56Z","timestamp":1559038316000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00281-008-0113-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,23]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["113"],"URL":"https:\/\/doi.org\/10.1007\/s00281-008-0113-8","relation":{},"ISSN":["1863-2297","1863-2300"],"issn-type":[{"value":"1863-2297","type":"print"},{"value":"1863-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,23]]}}}